Found 7 matching trials
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting PHASE3 PALO-10-01 is a clinical study assessing efficacy and safety of a single or...
Show More Location
Genesis Cancer Centre
Learn More & Join Trial
Aprepitant for Prevention of Acute and Delayed Nausea and Vomiting in Patients Receiving a High-emetogenic Dose of Cyclophosphamide for Peripheral Blood Stem Cells Harvesting PHASE3 Title of the study Aprepitant for prevention of acute and delayed nausea an...
Show More Location
Azienda Ospedaliera di Perugia - Hematology dept.
Learn More & Join Trial
Palonosetron for the Treatment of Nausea and Vomiting in Terminally Ill Patients PHASE2 The primary objective of this study is to determine the complete response (...
Show More Location
University of Michigan Comprehensive Cancer Center
Learn More & Join Trial
An Efficacy and Safety Study of Intravenous Palonosetron Administered as an Infusion and as a Bolus for the Prevention of Nausea and Vomiting PHASE3 PALO-15-17 is a clinical study assessing efficacy and safety of a single do...
Show More Location
N.N. Aleksandrov Republican Research Oncology and Medical Radiology Center, Department of Chemotherapy
Learn More & Join Trial
Aloxi for Prevention of Chemotherapy Induced Nausea and Vomiting in Malignant Glioma Patients Receiving Irinotecan With Bevacizumab PHASE2 1. Primary Objective:
* To determine the efficacy and tolerability of p...
Show More Location
Duke University Medical Center
Learn More & Join Trial
Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy NA In the present study, midazolam and palonosetron in combination were more e...
Show More Learn More & Join Trial
TEAS Combined With Triple Antiemetic Drugs to Prevent PONV in High-Risk Patients NA The goal of this clinical trial is to evaluate the effects of transcutaneou...
Show More Location
The First Affiliated Hospital, Zhejiang University School of Medicine
Learn More & Join Trial